Table 5 Overall survival, progression free survival and malignant progression free survival at 3, 5 and 10 years after surgery according to extent of resection.
From: Multimodal integrated approaches in low grade glioma surgery
EOR 100% | EOR 99–85% | EOR < 85% | |
|---|---|---|---|
Overall survival | |||
3 years | 97.72 (91.18–99.43) | 95.46 (88.36–98.27) | 71.61 (61.58–79.46) |
5 years | 94.92 (86.92–98.08) | 84.79 (75.24–90.88) | 52.46 (41.83–62.03) |
10 years | 86.58 (71.80–93.92) | 45.28 (33.52–56.31) | 19.21 (11.28–28.74) |
Progression free survival | |||
3 years | 90.83 (82.49–95.31) | 69.93 (59.27–78.30) | 49.26 (38.99–58.73) |
5 years | 70.94 (58.65–80.18) | 49.02 (38.20–58.97) | 26.82 (18.09–36.33) |
10 years | 46.49 (31.41–60.25) | 11.28 (5.47–19.44) | 3.76 (0.77–10.95) |
Malignant progression free survival | |||
3 years | 94.26 (86.75–97.57) | 87.77 (79.00–93.04) | 60.57 (50.18–69.45) |
5 years | 91.12 (82.08–95.71) | 67.93 (57.01–76.64) | 40.92 (30.79–50.77) |
10 years | 72.74 (54.86–84.47) | 26.87 (17.31–37.36) | 14.69 (7.76–23.71) |
